Wellgistics Health Announces 1-for-50 Reverse Stock Split to Avoid Nasdaq Delisting
WGRX sits 74% above its 52-week low of $0.07 on elevated volume (4.3× avg).
Summary
Wellgistics Health announced a 1-for-50 reverse stock split, effective May 26, 2026, which will reduce its outstanding shares from approximately 125.7 million to 2.5 million. This aggressive move is explicitly intended to increase the per-share trading price to regain compliance with Nasdaq's minimum bid price requirement, a critical delisting threat highlighted in the company's recent Q1 2026 10-Q filing. That filing, just yesterday, reported a drastic 85.6% revenue decline and a going concern warning, underscoring the company's precarious financial position. While the reverse split addresses a compliance issue, it does not resolve the fundamental operational and financial challenges, and such actions for micro-cap companies often fail to sustain long-term price stability. Traders will closely watch the stock's performance post-split and any further developments regarding its financial health and ability to maintain Nasdaq listing.
At the time of this announcement, WGRX was trading at $0.12 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $16.2M. The 52-week trading range was $0.07 to $3.00. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: ACCESS Newswire.